Broadrick Dale's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Jun 23, 2022
- Accession no.
- 0001567619-22-013309
- Filed
- Jun 23, 2022
- Trade date
- Jun 17-21, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $2.65K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadrick DaleCIK 0001677513 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 | Common Stock | PPurchaseAcquired | +600 | $3.80F1 | +$2,280 | 295,373 | Direct | |
| Jun 21, 2022 | Common Stock | PPurchaseAcquired | +100 | $3.68 | +$368 | 295,473 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $3.69 to $3.9375 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.